{"id":"https://openalex.org/W7128024366","doi":"https://doi.org/10.5306/wjco.v17.i2.115068","title":"From mutational signatures to practice: Artificial intelligence-guided repurposing for blast crisis chronic myeloid leukemia","display_name":"From mutational signatures to practice: Artificial intelligence-guided repurposing for blast crisis chronic myeloid leukemia","publication_year":2026,"publication_date":"2026-02-06","ids":{"openalex":"https://openalex.org/W7128024366","doi":"https://doi.org/10.5306/wjco.v17.i2.115068","pmid":"https://pubmed.ncbi.nlm.nih.gov/41810353"},"language":"en","primary_location":{"id":"doi:10.5306/wjco.v17.i2.115068","doi":"https://doi.org/10.5306/wjco.v17.i2.115068","is_oa":true,"landing_page_url":"https://doi.org/10.5306/wjco.v17.i2.115068","pdf_url":"https://rcastoragev2.blob.core.windows.net/6dcba2a5efd35e5c182cfd4eefab10d3/gkad986.pdf","source":{"id":"https://openalex.org/S2765028222","display_name":"World Journal of Clinical Oncology","issn_l":"2218-4333","issn":["2218-4333"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315735","host_organization_name":"Baishideng Publishing Group","host_organization_lineage":["https://openalex.org/P4310315735"],"host_organization_lineage_names":["Baishideng Publishing Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://rcastoragev2.blob.core.windows.net/6dcba2a5efd35e5c182cfd4eefab10d3/gkad986.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070409419","display_name":"Riya Karmakar","orcid":"https://orcid.org/0000-0003-0762-6770","observed_orcids":["https://orcid.org/0000-0003-0762-6770"]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Riya Karmakar","raw_affiliation_strings":["Department of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan","School of Engineering and Technology, Sanjivani University, Sanjivani Factory, Kopargaon 423603, Maharastra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan","institution_ids":["https://openalex.org/I148099254"]},{"raw_affiliation_string":"School of Engineering and Technology, Sanjivani University, Sanjivani Factory, Kopargaon 423603, Maharastra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124709781","display_name":"Aditya Kandalkar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aditya Kandalkar","raw_affiliation_strings":["Department of Information Technology, Sanjivani College of Engineering, Kopargaon 423603, Maharastra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Information Technology, Sanjivani College of Engineering, Kopargaon 423603, Maharastra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125213706","display_name":"Hsiang-Chen Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I148099254","display_name":"National Chung Cheng University","ror":"https://ror.org/0028v3876","country_code":"TW","type":"education","lineage":["https://openalex.org/I148099254"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Hsiang-Chen Wang","raw_affiliation_strings":["Department of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan","institution_ids":["https://openalex.org/I148099254"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069872673","display_name":"Arvind Mukundan","orcid":"https://orcid.org/0000-0002-7741-3722","observed_orcids":["https://orcid.org/0000-0002-7741-3722"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arvind Mukundan","raw_affiliation_strings":["School of Engineering and Technology, Sanjivani University, Sanjivani Factory, Kopargaon 423603, Maharastra, India. arvindmukund96@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Engineering and Technology, Sanjivani University, Sanjivani Factory, Kopargaon 423603, Maharastra, India. arvindmukund96@gmail.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08912522,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"2","first_page":"115068","last_page":"115068"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.08150000125169754,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.9729999899864197},{"id":"https://openalex.org/keywords/mutational-signatures","display_name":"mutational signatures","score":0.968999981880188},{"id":"https://openalex.org/keywords/molecular-subtyping","display_name":"molecular subtyping","score":0.5899999737739563},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/idh-inhibitors","display_name":"IDH inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.7749999761581421},{"id":"https://openalex.org/keywords/genomic-clusters","display_name":"genomic clusters","score":0.37599998712539673},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.367000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7746999859809875},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6438999772071838},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.49320000410079956},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.4799000024795532},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4519999921321869},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4113999903202057},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.41100001335144043},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.40939998626708984},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4059999883174896},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.38839998841285706},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3752000033855438},{"id":"https://openalex.org/C2483381","wikidata":"https://www.wikidata.org/wiki/Q18030194","display_name":"NPM1","level":5,"score":0.36890000104904175},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3635999858379364},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.3610000014305115},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.350600004196167},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33980000019073486},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.33640000224113464},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.334199994802475},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31949999928474426},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.2985999882221222},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.2971999943256378},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.29260000586509705},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2888000011444092},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.28690001368522644},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.2851000130176544},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2849999964237213},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.28029999136924744},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.2655999958515167},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.2621000111103058},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.26190000772476196},{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.2524000108242035},{"id":"https://openalex.org/C2994225774","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Gene mutation","level":4,"score":0.2517000138759613}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.5306/wjco.v17.i2.115068","doi":"https://doi.org/10.5306/wjco.v17.i2.115068","is_oa":true,"landing_page_url":"https://doi.org/10.5306/wjco.v17.i2.115068","pdf_url":"https://rcastoragev2.blob.core.windows.net/6dcba2a5efd35e5c182cfd4eefab10d3/gkad986.pdf","source":{"id":"https://openalex.org/S2765028222","display_name":"World Journal of Clinical Oncology","issn_l":"2218-4333","issn":["2218-4333"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315735","host_organization_name":"Baishideng Publishing Group","host_organization_lineage":["https://openalex.org/P4310315735"],"host_organization_lineage_names":["Baishideng Publishing Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:41810353","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41810353","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World journal of clinical oncology","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:12968529","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12968529/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12968529/pdf/wjco-17-2-115068.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"World J Clin Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.5306/wjco.v17.i2.115068","doi":"https://doi.org/10.5306/wjco.v17.i2.115068","is_oa":true,"landing_page_url":"https://doi.org/10.5306/wjco.v17.i2.115068","pdf_url":"https://rcastoragev2.blob.core.windows.net/6dcba2a5efd35e5c182cfd4eefab10d3/gkad986.pdf","source":{"id":"https://openalex.org/S2765028222","display_name":"World Journal of Clinical Oncology","issn_l":"2218-4333","issn":["2218-4333"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310315735","host_organization_name":"Baishideng Publishing Group","host_organization_lineage":["https://openalex.org/P4310315735"],"host_organization_lineage_names":["Baishideng Publishing Group"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"World Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7128024366.pdf","grobid_xml":"https://content.openalex.org/works/W7128024366.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W2807675497","https://openalex.org/W4210922856","https://openalex.org/W4386143366","https://openalex.org/W4388000581","https://openalex.org/W4389609702","https://openalex.org/W4390621251","https://openalex.org/W4391512773","https://openalex.org/W4393279730","https://openalex.org/W4401253287","https://openalex.org/W4403838320","https://openalex.org/W4404490792","https://openalex.org/W4409416427","https://openalex.org/W4410382291","https://openalex.org/W4416441513"],"related_works":[],"abstract_inverted_index":{"This":[0],"article":[1,149],"of":[2,45,59,62,164],"discusses":[3],"blast":[4,46],"crisis":[5],"chronic":[6],"myeloid":[7],"leukemia":[8],"(CML),":[9],"which":[10],"is":[11],"the":[12,42,57,60,162,184,189],"most":[13],"aggressive":[14],"CML":[15],"phase":[16],"marked":[17],"by":[18],"rapid":[19,239],"progression,":[20],"substantial":[21],"mutational":[22,67],"complexity,":[23],"and":[24,37,48,52,92,99,133,169,188,199,208,218,233],"resistance":[25],"to":[26,40,113,215],"standard":[27],"tyrosine":[28,230],"kinase":[29,101,231],"therapies.":[30],"The":[31,108],"methodology":[32],"combines":[33],"whole":[34],"exome":[35],"sequencing":[36],"machine":[38],"learning":[39],"identify":[41],"molecular":[43,167],"subtypes":[44],"crisis-CML":[47],"repurpose":[49],"existing":[50],"Food":[51],"Drug":[53],"Administration-approved":[54],"drugs":[55],"on":[56,220],"basis":[58],"Catalogue":[61],"Somatic":[63],"Mutations":[64],"in":[65,193,226,238],"Cancer":[66],"patterns.":[68],"In":[69],"a":[70,152],"pilot":[71],"cohort":[72,186],"(n":[73],"=":[74],"7),":[75],"three":[76],"exploratory":[77],"genomic":[78],"clusters":[79],"were":[80],"identified:":[81],"Breast":[82],"cancer":[83,120],"gene":[84,121],"2/tumor":[85,122],"protein":[86,123],"p53;":[87],"isocitrate":[88],"dehydrogenases":[89],"(IDH)":[90],"1":[91],"IDH":[93,125],"2":[94],"ten":[95,129],"eleven":[96,130],"translocation":[97,131],"2;":[98],"Janus":[100],"(JAK)":[102],"2/colony":[103],"stimulating":[104,139],"factor":[105,140],"3":[106,141],"receptor.":[107],"results":[109],"present":[110],"an":[111],"opportunity":[112],"evaluate":[114],"poly(ADP":[115],"ribose)":[116],"polymerase":[117],"inhibitors":[118,126,135],"(breast":[119],"p53),":[124],"(IDH1/2":[127],"or":[128,137],"2),":[132],"JAK":[134],"(JAK2":[136],"colony":[138],"receptor)":[142],"as":[143,151,183],"actionable":[144],"therapeutics.":[145],"Moreover,":[146],"this":[147],"e":[148],"presents":[150],"strategic":[153],"framework":[154],"for":[155,175,191,235],"mutation-targeted":[156],"therapy":[157],"targeting":[158],"treatment-resistant":[159],"leukemias,":[160],"highlighting":[161],"potential":[163],"artificial":[165],"intelligence-driven":[166],"stratification":[168],"uncovering":[170],"clinically":[171],"relevant":[172],"therapeutic":[173],"options":[174],"malignancies.":[176],"However,":[177],"limitations":[178],"should":[179,202],"be":[180],"acknowledged,":[181],"such":[182],"limited":[185],"size":[187],"necessity":[190],"validation":[192],"larger":[194],"multicenter":[195],"investigations.":[196],"Prospective":[197],"registries":[198],"trial":[200],"enrollment":[201],"test":[203],"signature-defined":[204],"micro-cohorts":[205],"with":[206,229],"versioned":[207],"auditable":[209],"reporting.":[210],"These":[211],"mappings":[212],"are":[213],"designed":[214],"provide":[216],"hypotheses":[217],"depend":[219],"independent":[221],"functional":[222],"validation,":[223],"prioritizing":[224],"safety":[225],"combination":[227],"methods":[228],"inhibitors,":[232],"allows":[234],"practical":[236],"implementation":[237],"turnaround":[240],"environments.":[241]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-02-07T00:00:00"}